These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4355120)

  • 21. Pellicle-associated structures in the amastigote stage of Trypanosoma cruzi and Leishmania species.
    Gardener PJ
    Ann Trop Med Parasitol; 1974 Jun; 68(2):167-76. PubMed ID: 4212227
    [No Abstract]   [Full Text] [Related]  

  • 22. Trypanocidal effects of promethazine.
    Fernández AR; Fretes R; Rubiales S; Lacuara JL; Paglini-Oliva P
    Medicina (B Aires); 1997; 57(1):59-63. PubMed ID: 9435371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design.
    Aguirre G; Cabrera E; Cerecetto H; Di Maio R; González M; Seoane G; Duffaut A; Denicola A; Gil MJ; Martínez-Merino V
    Eur J Med Chem; 2004 May; 39(5):421-31. PubMed ID: 15110968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trypanocidal activity of 1,3,7-trihydroxy-2-(3-methylbut-2-enyl)-xanthone isolated from Kielmeyera coriacea.
    Caleare Ade O; Lazarin-Bidóia D; Cortez DA; Ueda-Nakamura T; Dias Filho BP; Silva Sde O; Nakamura CV
    Parasitol Int; 2013 Oct; 62(5):405-11. PubMed ID: 23680754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New potent 5-nitrofuryl derivatives as inhibitors of Trypanosoma cruzi growth. 3D-QSAR (CoMFA) studies.
    Aguirre G; Boiani M; Cabrera E; Cerecetto H; Di Maio R; González M; Denicola A; Sant'anna CM; Barreiro EJ
    Eur J Med Chem; 2006 Apr; 41(4):457-66. PubMed ID: 16497414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trypanosoma cruzi: ultrastructural changes produced by an anti-trypanosomal factor from Pseudomonas fluorescens.
    Mercado TI; Butany JW; Ferrans VJ
    Exp Parasitol; 1986 Feb; 61(1):65-75. PubMed ID: 3080328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trypanosoma cruzi: trypanocidal effect of 2(3)-tert-butyl-4-hydroxyanisole (BHA) on several strains of epimastigote and trypomastigote forms.
    Aldunate J; Ojeda JM; Repetto Y; Letelier ME; Spencer P
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1994 Oct; 109(2):119-27. PubMed ID: 7881815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-Nitrobenzaldehyde thiosemicarbazone: a new compound derived from S-(-)-limonene that induces mitochondrial alterations in epimastigotes and trypomastigotes of Trypanosoma cruzi.
    Britta EA; Scariot DB; Falzirolli H; da Silva CC; Ueda-Nakamura T; Dias Filho BP; Borsali R; Nakamura CV
    Parasitology; 2015 Jun; 142(7):978-88. PubMed ID: 25711881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective inhibition of k-DNA synthesis of Trypanosoma cruzi and Leishmania tarentolae by berenil and ethidium bromide [proceedings].
    Leon W
    An Acad Bras Cienc; 1978 Dec; 50(4):597-8. PubMed ID: 373537
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of nifurtimox and benznidazole upon glutathione and trypanothione content in epimastigote, trypomastigote and amastigote forms of Trypanosoma cruzi.
    Maya JD; Repetto Y; Agosín M; Ojeda JM; Tellez R; Gaule C; Morello A
    Mol Biochem Parasitol; 1997 May; 86(1):101-6. PubMed ID: 9178272
    [No Abstract]   [Full Text] [Related]  

  • 31. Toxicity of oleoresins from the genus Copaifera in Trypanosoma cruzi: a comparative study.
    Izumi E; Ueda-Nakamura T; Veiga-Júnior VF; Nakamura CV
    Planta Med; 2013 Jul; 79(11):952-8. PubMed ID: 23824551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiparasitic activity of aromatic diamidines is related to apoptosis-like death in Trypanosoma cruzi.
    De Souza EM; Menna-Barreto R; Araújo-Jorge TC; Kumar A; Hu Q; Boykin DW; Soeiro MN
    Parasitology; 2006 Jul; 133(Pt 1):75-9. PubMed ID: 16563202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taiwaniaquinoid and abietane quinone derivatives with trypanocidal activity against T. cruzi and Leishmania spp.
    Ramírez-Macías I; Marín C; Es-Samti H; Fernández A; Guardia JJ; Zentar H; Agil A; Chahboun R; Alvarez-Manzaneda E; Sánchez-Moreno M
    Parasitol Int; 2012 Sep; 61(3):405-13. PubMed ID: 22366342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mode of action of intercalating drug, cis-Pt(II)(DDH)Cl2, cis-Pt(II)(DDH) (metafluorobenzoic)2, and cis-Pt(II)(DDH)(mucubromic)2, on Trypanosoma cruzi.
    Ruiz-Perez LM; Osuna A; Lopez MC; Castanys S; Gammaro F; Craciunescu D; Alonso C
    Trop Med Parasitol; 1987 Mar; 38(1):45-8. PubMed ID: 3299659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trypanosoma cruzi: in vitro activity of Epoxy-alpha-Lap, a derivative of alpha-lapachone, on trypomastigote and amastigote forms.
    Bourguignon SC; Castro HC; Santos DO; Alves CR; Ferreira VF; Gama IL; Silva FC; Seguins WS; Pinho RT
    Exp Parasitol; 2009 Jun; 122(2):91-6. PubMed ID: 19285074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrastructural alterations and peroxide formation induced by naphthoquinones in different stages of Trypanosoma cruzi.
    Docampo R; De Souza W; Cruz FS; Roitman I; Cover B; Gutteridge WE
    Z Parasitenkd; 1978 Nov; 57(3):189-98. PubMed ID: 216177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitrofurylsemicarbazone rhenium and ruthenium complexes as anti-trypanosomal agents.
    Otero L; Aguirre G; Boiani L; Denicola A; Rigol C; Olea-Azar C; Maya JD; Morello A; González M; Gambino D; Cerecetto H
    Eur J Med Chem; 2006 Nov; 41(11):1231-9. PubMed ID: 16828524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrastructural alterations of Trypanosoma cruzi kinetoplast induced by the interaction of a trypanocidal drug (hydroxystilbamidine) with the kinetoplast DNA.
    Delain E; Brack C; Riou G; Festy B
    J Ultrastruct Res; 1971 Oct; 37(1):200-18. PubMed ID: 5000212
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of Chagas' disease].
    Apt W
    Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug-resistant epimastigotes of Trypanosoma cruzi and persistence of this phenotype after differentiation into amastigotes.
    Nirdé P; Larroque C; Barnabé C
    C R Acad Sci III; 1995 Dec; 318(12):1239-44. PubMed ID: 8745639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.